Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DBU4N1
|
|||
| Drug Name |
AVTX-002
|
|||
| Synonyms |
quisovalimab
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Non-eosinophilic asthma [ICD-11: CA23] | Phase 2 | [1] | |
| Company |
Avalo Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Herpes virus entry mediator ligand (CD258) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05288504) A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma. U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Avalo Therapeutics | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.